A study found that the N6-methyladenosine demethylase ALKBH5 promoted the N6-methyladenosine demethylation of GLUT4 mRNA, increasing GLUT4 mRNA stability in a YTHDF2-dependent manner and enhancing glycolysis in drug-resistant BC cells. The gene discussed is SLC2A4; the disease is breast cancer.